– UK, Manchester – Yourgene Health PLC (LON: YGEN), a leading international molecular diagnostic group, today announced the appointment of Mary Tavener to its Board as a Non-executive Director effective immediately.
“Mary has extensive experience within the life sciences sector on AIM, which will be invaluable to the Group as we grow and expand. I look forward to working alongside Mary as we continue to engage with our extensive pipeline of exciting opportunities,” said Board Chairman, Adam Reynolds.
Mary will also join the Audit Committee as its chair.
About Mary Tavener
Mary has extensive experience in the healthcare sector, having previously been CFO and board member of AIM-listed Advanced Medical Solutions plc for 19 years during which the company saw 15 years of consecutive growth. Mary is a Member of the Chartered Institute of Management Accountants and a Fellow of the Association of Corporate Treasurers.
Mary has a degree in Chemistry from the University of Oxford.
Mary is also a Senior Independent NED of Abingdon Health and NED for Allergy Therapeutics plc.
About Yourgene Health
Yourgene Health is an international molecular diagnostics group which develops integrated genomic technologies and services enabling precision medicine. The group works in partnership with global leaders in DNA technology to advance diagnostic science.
Yourgene primarily develops, manufactures, and commercializes simple and accurate molecular diagnostic solutions, for reproductive health, precision medicine and now infectious diseases. The Group’s flagship products include non-invasive prenatal tests for Down’s Syndrome and other genetic disorders, Cystic Fibrosis screening tests, invasive rapid aneuploidy tests, and a recent extension into the oncology space with DPYD genotyping.
The launch of Yourgene Genomic Services has enabled Yourgene to offer a global laboratory service network equipped to be a full life-cycle partner for clinical, research, and pharmaceutical organizations to support partners at the preclinical, clinical, and post-market stages to develop, manufacture, obtain regulatory approval and commercialize new products and services. In addition, Yourgene Genomic Services offers an NIPT and high throughput COVID testing service.
In August 2020, Yourgene acquired Coastal Genomics, Inc., a sample preparation technology company based in Vancouver, Canada, enabling the Company to extend its offering and IP portfolio in the DNA sample preparation sector. The acquisition increased Yourgene’s geographical penetration into the US and Canada, supplementing existing coverage in the UK, Europe, MEA, and Asia.
For more information: https://www.yourgene-health.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.